Nortem Biogroup (XPAR:MLBIO) Gross-Profit-to-Asset % : 56.08% (As of Dec. 2022)

View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Nortem Biogroup's annualized Gross Profit for the quarter that ended in Dec. 2022 was €6.42 Mil. Nortem Biogroup's average Total Assets over the quarter that ended in Dec. 2022 was €11.45 Mil. Therefore, Nortem Biogroup's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2022 was 56.08%.

Nortem Biogroup Gross-Profit-to-Asset % Historical Data

The historical data trend for Nortem Biogroup's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Gross-Profit-to-Asset % Chart

Nortem Biogroup Annual Data

Trend

Dec21

Dec22

Gross-Profit-to-Asset %

59.51

56.08

Nortem Biogroup Semi-Annual Data
	Dec21	Dec22
Gross-Profit-to-Asset %	59.51	56.08

Competitive Comparison of Nortem Biogroup's Gross-Profit-to-Asset %

For the Packaged Foods subindustry, Nortem Biogroup's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nortem Biogroup's Gross-Profit-to-Asset % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nortem Biogroup's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Nortem Biogroup's Gross-Profit-to-Asset % falls into.

Nortem Biogroup Gross-Profit-to-Asset % Calculation

Nortem Biogroup's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2022 )	/	( (Total Assets (A: Dec. 2021 )	+	Total Assets (A: Dec. 2022 ))	/ count )
	=	6.422	/	( (9.434	+	13.468)	/ 2 )
	=	6.422	/	11.451
	=	56.08 %

Nortem Biogroup's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2022 )	/	( (Total Assets (Q: Dec. 2021 )	+	Total Assets (Q: Dec. 2022 ))	/ count )
	=	6.422	/	( (9.434	+	13.468)	/ 2 )
	=	6.422	/	11.451
	=	56.08 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (Dec. 2022) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Nortem Biogroup Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nortem Biogroup (XPAR:MLBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500

Website

https://www.nortembiogroup.com

Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines